Displaying 13 - 24 of 40
Immune-Mediated and Cholestatic Diseases
Guiding your Patients: Addressing Cholestatic Pruritus in PBC

Guiding your Patients: Addressing Cholestatic Pruritus in PBC

Webcasts
View
Viral Hepatitis
Exploring Functional Cure in Chronic Hepatitis B

Exploring Functional Cure in Chronic Hepatitis B

Webcasts
View
Viral Hepatitis
Quantitative hepatitis B surface antigen (qHBsAg) is a useful biomarker for Chronic Hepatitis B

Quantitative hepatitis B surface antigen (qHBsAg) is a useful biomarker for Chronic Hepatitis B

PDF
View
Immune-Mediated and Cholestatic Diseases

GSK: "Investigating IBAT inhibition in itch – a new tool for an age-old problem?" (Complete Session)

Webcasts
View
Immune-Mediated and Cholestatic Diseases

GSK: "Practical tips towards providing holistic care to patients with PBC" (Complete Session)

Webcasts
View
Viral Hepatitis

GSK: “Looking to the future of hepatitis B: how can we achieve functional cure?” (Complete Session)

Webcasts
View
Viral Hepatitis

GSK: "Looking To The Future Of Hepatitis B: An Expert Review Of Quantitative Hepatitis B Surface Antigen Assessment” (Complete...

Webcasts
View
Viral Hepatitis

Introduction

Webcasts
View
Immune-Mediated and Cholestatic Diseases

What is the unmet burden of itch from an HCP perspective?

Webcasts
View
Immune-Mediated and Cholestatic Diseases

How can we face itch in the present?

Webcasts
View
Viral Hepatitis

Benefits and barriers to achieving functional cure

Webcasts
View
Viral Hepatitis

The importance of quantitative hepatitis B surface antigen in achieving functional cure: A clinical perspective

Webcasts
View